LogicBio Therapeutics, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows, 23 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-10-25: Reporting owner Arix Bioscience Holdings Ltd | Arix Bioscience plc; Form 3/A; Security Series B Convertible Preferred Stock; Transaction Holding.
- 2018-10-23: Reporting owner Arix Bioscience plc | Arix Bioscience Holdings Ltd; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2018-10-23: Reporting owner OrbiMed Israel GP II, L.P. | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2018-10-23: Reporting owner OrbiMed Israel GP II, L.P. | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC; Form 4; Security Series B Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-10-25 holding as of filing | Arix Bioscience Holdings Ltd | Arix Bioscience plc 10% Owner | 10% Owner | 3/A | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2018-10-25 | ||
| 2018-10-23 | Arix Bioscience plc | Arix Bioscience Holdings Ltd 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,352,775 0 owned after | $0.00 | 2018-10-26 | |
| 2018-10-23 | OrbiMed Israel GP II, L.P. | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −2,678,571 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | OrbiMed Israel GP II, L.P. | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −3,046,943 2,279,023 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | OrbiMed Israel GP II, L.P. | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC | OrbiMed Capital GP VI LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −4,352,775 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | Kariv Tomer Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,288,116 692,982 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | Kariv Tomer Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −696,444 328,339 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | Kariv Tomer Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −627,105 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | Ioannidou Sofia Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,611,665 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | O'Connell Daniel P Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −4,352,775 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | Chimovits Erez Director | 4 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −2,678,571 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-23 | Chimovits Erez Director | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −3,046,943 0 owned after | $0.00 | 2018-10-25 | |
| 2018-10-19 holding as of filing | Arix Bioscience plc 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2018-10-19 | ||
| 2018-10-18 holding as of filing | Ioannidou Sofia Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | Kariv Tomer Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By Pontifax Investment Fund | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | Kariv Tomer Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By Pontifax Investment Fund | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | Kariv Tomer Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By Pontifax Investment Fund | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | Chimovits Erez Director | 3 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | Chimovits Erez Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | OrbiMed Israel GP II, L.P. | OrbiMed Capital GP VI LLC | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 3 | Series A Convertible Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | OrbiMed Israel GP II, L.P. | OrbiMed Capital GP VI LLC | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | OrbiMed Israel GP II, L.P. | OrbiMed Capital GP VI LLC | OrbiMed Advisors Israel II Ltd | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnotes | Holding | no price filed | 2018-10-18 | ||
| 2018-10-18 holding as of filing | O'Connell Daniel P Director | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2018-10-18 |